We are currently building a list of upcoming conferences, including the initial ones listed below. If you would like your conference to be included in this list then please contact firstname.lastname@example.org.If you are about to present (or have recently presented) at a national or international life science or medical conference that is not currently on this list and would like to deposit your poster or slide presentation with us then please follow the simple online submission form.
September 2 - 4, 2014
World Congress of Reproductive Biology 2014
WCRB 2014 will be held September 2nd through September 4th 2014 at the Edinburgh International Conference Centre (EICC), a world class conference centre. The Congress will be held in EICC2, a new extension which offers state-of-the-art facilities adjacent and directly linked to the main EICC building. Designed by collaboration between all six participating societies, the Congress will feature a truly international scientific programme comprising a vibrant mixture of lectures, symposia, oral and poster communications, covering the breadth of interests in the field of reproductive biology. The programme will feature talks by experts from all around the world and be complemented by an exciting social programme to provide ample opportunities for delegates to meet and socialise with collaborators, old and new. There will also be a range of satellite events organised to precede the World Congress which will include the SRF Annual Conference for 2014.
September 3 - 4, 2014
Respiratory Genetics 2014
This September, the University of Nottingham are hosting a brand new Respiratory Genetics conference with support from the British Association for Lung Research (BALR). This is an opportunity for the international respiratory genetics community to explore the genetic basis of a range of respiratory diseases including Asthma, Chronic Obstructive Pulmonary Disease (COPD), Interstitial Lung Disease (ILD), Idiopathic Pulmonary Fibrosis (IPF), Cystic Fibrosis (CF) and Lymphangioleiomyomatosis (LAM). However, any aspect of Respiratory Genetics will be welcome. In addition to presentations from leading and upcoming researchers in the field, ample time has been allocated to allow discussion, networking and socialising opportunities.
September 7 - 10, 2014
European Conference on Computational Biology 2014
ECCB'14 is the key European computational biology event in 2014 gathering scientists working at the intersection of a broad range of disciplines including computer science, mathematics, biology, and medicine. New challenges are emerging today in these fields with the recent advances in low-cost ultra-fast sequencing, bio-imaging and big-data approaches. Databases and software are evolving especially rapidly. Nonetheless, new algorithms are still required to improve computing with massive biological or biomedical data. Indeed, multi-scale integrative analyses are struggling to deal with the enormous complexity of biological systems modeling and the "data deluge" that results from next-generation sequencing technologies. ECCB'14 is the 13th edition of the ECCB conference series, which in 2014 will take place in the historic city of Strasbourg in the north-east of France. ECCB'14 will incorporate JOBIM, the annual French bioinformatics conference. An inter-regional and cross-border Organizing Committee has been formed, joining the Champagne-Ardennes (Reims), Lorraine (Nancy), and Alsace (Strasbourg) regions in France together with Belgium (Leuven), Germany (Saarbrücken), Luxembourg, and Switzerland (Basel). We are all looking forward to welcoming you in Strasbourg for ECCB'14 !
September 10 - 13, 2014
3rd International Biennial Conference on La and Related Proteins (LARPs) 2014
Conference abstract submission - deadline passed
Warrenton, VA, USA
The LARP society (LARPSOC) comprises scientists from many disciplines with a shared interest in the study of La-motif containing proteins such as genuine La and La-related proteins (LARPs). Since their initial characterization, genuine La proteins have been shown to function in the metabolism of a wide spectrum of non-coding and coding RNAs, several of which have been implicated in human disease. More recently, the study of LARPs in various eukaryotic species has expanded on the known functions of these proteins, such as participating in mRNA translation. The aims of LARPSOC are both to promote research into La-motif containing proteins and to provide a discussion forum, in the form of a website and meetings held alternate-yearly, around this fascinating area of discovery.
September 15, 2014
New York Academy of Sciences 2014 - Click Chemistry in Biology and Medicine: New Developments and Strategies
Conference abstract submission - deadline passed
New York, NY, USA
Inspired by the complexity that nature achieves from a just handful of building blocks, K. Barry Sharpless began looking for a reliable method for discovering new chemical connectivity in the mid-1990s. In 1998 he coined the now-familiar term "click chemistry.” The three 'perfect' click chemistry reactions — copper-catalyzed azide-alkyne cycloaddition (CuAAC), thiol-ene reaction, and sulfur(VI) fluoride exchange (SuFEx) — offer a method with far-reaching potential in drug discovery and biomedical research. This symposium explores recent developments in click chemistry, including the discovery of new click reactions, which address fundamental challenges in biology and provide new technologies for disease diagnosis and therapy. The symposium brings together pioneers in the field and young academic investigators. Late-breaking oral abstract presentations will be given, and a poster session will highlight the breadth and depth of cutting-edge research currently underway.
September 18 - 21, 2014
Society for Research in Psychopathology Meeting 2014
Evanston, IL, USA
The Society for Research in Psychopathology (SRP) is an organization of established psychopathology researchers. The Society holds an annual meeting each Fall that provides a forum for presentation and discussion of current psychopathology research. The meeting includes symposia, paper sessions, invited speakers, and poster presentations, and many opportunities for collegial discussion. Members, their graduate students, and interested colleagues attend.
September 26 - 28, 2014
4th “Performing Arts Medicine” International CEIMArs Convention 2014
With support from F1000Posters, CEIMArs is pleased to announce the program for the 4th Edition of the International Performing Arts Medicine Convention led by the honorary committee: Emma Dante, Simone Ferraresi, Paola Folli and Marcello Giordani. Specifically suggested for participation are doctors, physiotherapists, speech and voice pathologists, psychologists, bioengineers, actors, dubbers, dancers, singers, musicians, circus performers etc., this event presents both theoretical and practical lectures and workshops, original and unpublished research on medicine and theatre, stage science and humanities.
September 26 - 28, 2014
Italian Interdisciplinary Center for Performing Arts Medicine (CEIMARS) International Convention 2014
October 8, 2014
The New York Academy of Sciences 2014: Pharmacologic Resolution of Inflammation as a Novel Therapeutic Approach
New York City, USA
Uncontrolled, chronic inflammation is now considered a major component of many widespread diseases, which are now well-recognized as 'inflammatory diseases.' These include arthritis, asthma, atherosclerosis and peripheral vascular disease, Alzheimer’s disease, periodontal disease and cancer. There is general agreement that inflammation is not likely to be the causative factor in these diseases, but that it plays a key role in disease progression, tissue dysfunction and ultimately organ failure. In recent years, evidence has emerged that resolution of inflammation is a biochemically active process driven by multiple chemical mediators. Elucidation of the biochemical pathways contributing to the resolution of inflammation has provided many new anti-inflammatory targets and an opportunity for resolution-based pharmacology for treatment and prevention of inflammatory diseases. This symposium reviews recent discoveries and advances in the field, and demonstrates how this work translates into new approaches and new pharmacology to treat old diseases.
October 9 - 12, 2014
39th Symposium on Hormones and Cell Regulation 2014
Mont Ste Odile, France
"Inositol lipid signaling: from molecular mechanisms to human pathologies": Phosphoinositides and inositol phosphates interact with and modulate the recruitment and activation of key regulatory proteins and in doing so control diverse functions including cell growth, proliferation and movement, apoptosis, cytoskeletal dynamics, insulin action, vesicle trafficking and nuclear functions. Controlling the levels of inositol signalling molecules and their subcellular compartmentalization is likely to be critical. This meeting will bring together scientists from different backgrounds to discuss how understanding inositol signaling may be used to target human diseases like cancer and heart diseases that manifest themselves when inositol signalling is deregulated.
October 10, 2014
The New York Academy of Sciences 2014: New Frontiers in the Neurobiology of Mental Illness
New York, NY, USA
One in four Americans suffers from mental illness such as schizophrenia, depression, fear and anxiety disorders, autism, and other psychiatric disorders. These numbers pose an enormous socioeconomic burden: adult suicide rates are rising steadily; many at-risk mentally ill patients experience homelessness and incarceration rather than hospitalization; and global costs of mental illness—which often affect otherwise healthy, working-age adults—are estimated to exceed US$16 trillion by 2030. Today, prevention and better treatment of mental illness may finally be within reach due to recent breakthroughs in neuroscience—vastly improving our understanding of the genetic, epigenetic, molecular, and cellular mechanisms; structure; and neuronal circuitry underlying normal and pathological brain function. This conference will explore the translation of these findings into pharmacological, psychotherapeutic, and other interventions to improve mental health. A keynote lecture by The Honorable Patrick J. Kennedy will address strategies to simultaneously abolish the stigma surrounding mental illness in order to fully realize the new treatments’ potential. Free Symposium. Advance registration required.
October 15 - 17, 2014
International Experimental Biology and Medicine Conference 2014
San Diego, CA, USA
ith the goal of translating the globalization of EBM to a worldwide membership for SEBM, the SEBM Council approved the opening of an SEBM/EBM China Outreach Office. With 50% of the EBM manuscripts coming from China, and the tremendous expansion of biomedical research in that country, it was the logical first location for an SEBM/EBM Outreach Office. One of the goals of the SEBM/EBM ChinaOutreach office are to increase the profile of SEBM and EBM in China and to meet this goal, a jointly planned annual international conference was held in Shanghai in 2013. Following our inaugural event in 2013, the 2014 IEBMC will be a three day conference again held at the Purple Mountain Hotel in Shanghai China on October 15th to 17th. The focus of the 2014 IEBMC will be “Stem Cell Biology and Human Diseases.” The EBM Associate Editor for Stem Cell Biology, Jian Feng, is co-Chairing the 2014 IEBMC Scientific Planning Committee with Wei-Qiang Gao serving as the other co-Chair. ;There will be workshops for students and post doctoral fellows on “How to Publish Your Manuscript” and on “Career Development”.
November 3, 2014
The New York Academy of Sciences 2014 - Gene Network Changes in Alzheimer’s Disease: Potential Points for Therapeutic Intervention
Conference abstract submission - deadline 26 September 2014
New York, NY, USA
Microglia, the resident innate immune cells of the central nervous system (CNS), have emerged as critical players in normal CNS function as well as in the progression of major disorders such as Alzheimer’s disease (AD). Although microglia have been traditionally categorized into either the pro-inflammatory ‘M1’ or the anti-inflammatory ‘M2’ phenotype, recent studies have uncovered a previously unappreciated spectrum of microglial phenotypes involved in a range of important processes including synaptic homeostasis and neurotrophic support. In order to address whether this spectrum is altered in AD, it is first necessary to elucidate the molecular signatures underlying these microglial phenotypes. Recent efforts have therefore applied next generation sequencing techniques and approaches such as weighted gene co-expression network analysis, a systems biology method for describing the correlation patterns among genes, to better understand these signatures at the genomic level. Remarkably, the most perturbed gene networks identified in AD brains fall squarely within microglial pathways and these findings are consistent with previous genome wide association studies linking specific microglial genes to AD risk. Furthermore, parallel work examining the peripheral immune system indicates that monocytes may exhibit some of the same gene network changes, opening the possibility of developing new peripheral biomarkers. This symposium will therefore focus on the identification of microglial gene network signatures associated with AD, how these phenotypes might be modulated to alter the course of AD pathology, and how a better understanding of peripheral immune biology may lead to the development of therapeutics and peripheral biomarkers for AD.
November 6 - 9, 2014
Society for Immunotherapy of Cancer (SITC) Meeting 2014
National Harbor, MD
Known as the premier destination for scientific exchange, education and networking in the cancer immunotherapy community, attendees will be a part of more than 1,100 anticipated basic, clinical and translational scientists from academia, government and industry, along with other top medical professionals from around the world, all dedicated to improving cancer patient outcomes through cancer immunotherapy. The SITC 2014 experience includes cutting-edge research and timely educational sessions that serve as catalysts for advancing the field - all in a personal and friendly environment that bridges the bench to bedside gap between translational research, development and clinical practice.
November 11 - 13, 2014
The New York Academy of Sciences 2014: Shaping the Developing Brain: Prenatal through Early Childhood
New York City, USA
The future success of a child is crucially dependent upon the earliest stages of brain development, during pregnancy and infancy. Scientific research from multiple academic and medical disciplines has shown that the changes that take place during this early period of brain development can profoundly shape the rest of a child's life, and affect long-term health, well-being, and cognitive ability. As a child grows — from inside the womb through the first few years of life — massive changes take place in the connectivity and plasticity of the brain. Deepening our understanding of the connection between a child’s early behavioral milestones and their brain’s structural and neural development is a critical first step for promoting healthy brain development, as well as improving treatments for developmental and learning disorders. Additionally, functional or dysfunctional social and family relationships, socioeconomic status/poverty, stress, nutrition, and other environmental experiences produce lasting effects on the brain and impact how children will respond to adversity, how they will interact with their peers, and whether they will succeed in school and throughout their lives. This 2.5-day conference will convene leading researchers with expertise in the fundamental stages of early brain development, and will focus on the connection between research and improved outcomes for children. Conference speakers will present the latest discoveries from cognitive neuroscience and experimental psychology regarding typical and atypical development of human learning and memory, emotion, and social behavior in the first few years of life. They will also explore socioeconomic, family, and nutritional factors that can affect brain and behavior. The conference will highlight educational practices, health and nutrition practices, applied research, and government policy with the potential for enhancing healthy brain development and improving outcomes for at-risk children. This conference will feature a dedicated session: Spotlight on Nutrition and Brain Development, co-presented with The Sackler Institute for Nutrition Science, a program of the New York Academy of Sciences.
December 1 - 4, 2014
British Society of Immunology Annual Meeting 2014
The British Society for Immunology Congress is the BSI’s flagship event. As one of the oldest and most active immunology societies in the world, the BSI annual congress has established itself as the must attend immunology event of the year, where leading immunology specialists from all over the world come together under one roof. The congress enables the exchange of ideas and knowledge to facilitate research and collaborations focusing on immunology. For 2014 the BSI Committee is delighted to be holding the Congress at the Brighton Centre, which is regarded as one of the finest venues in the country, offering top class conference facilities to organisers and delegates alike.
December 5 - 7, 2014
25th International Symposium on Amyotrophic Lateral Sclerosis and Motor Neurone Disease 2014
Our International Symposium is the largest medical and scientific conference on MND/ALS. It is the premier event in the MND research calendar, attracting over 800 delegates, representing the energy and dynamism of the global MND research community.
December 8 - 9, 2014
9th BENELUX Bioinformatics Conference 2014
Luxembourg City, Luxembourg
BBC 2014 is the second edition of the Benelux Bioinformatics Conference that will be held in Luxembourg. The conference program will include oral presentations from all fields of bioinformatics, a poster session, talks by international speakers and a network discussion. The conference will create also opportunity for sponsors, who might present software demos and commercial products. Each BBC conference attracts up to 200 researches from both academic and public research institutions as well as from private sector. The multi-environmental and interdisciplinary character of the conference allows sharing various ideas among participants interested in fundamental biological research, biotechnologies and computational biology. Topics discussed during the BBC conferences, include, among others, research on biological networks, structural bioinformatics, and the analysis of high-throughput sequencing data and micro-array expression data. We are looking forward to meeting you in Luxembourg!
December 9, 2014
New York Academy of Sciences 2014 - Diabetic Kidney Disease: Drug Discovery and Clinical Development Challenges
Conference abstract submission - deadline 31 October 2014
New York, NY, USA
Diabetic nephropathy is the leading cause of end-stage renal disease (ESRD) in the United States, and is associated with elevated cardiovascular morbidity and mortality. The progression of kidney disease in patients with diabetes occurs over many years, and interventions such as glycemic control and blood pressure lowering with inhibitors of the renin-angiotensin-aldosterone system have been shown to slow this progression. Despite the standard of care, the prevalence of patients with ESRD secondary to diabetic nephropathy continues to rise. Recently, several drugs in late clinical development have failed due to lack of efficacy and/or safety concerns. Finding and validating new targets to treat this condition have proven challenging due to lack of a deep understanding of the pathogenesis of diabetic nephropathy and biomarkers that can reliably define the rate of kidney function loss. This symposium reviews recent experimental approaches that may lead to the identification of targets for preventive or therapeutic interventions, and discusses the current challenges in the clinical development of therapeutic agents to treat diabetic kidney disease.